Acasti Pharma (CVE:ACST) Stock Price Up 1.8% – Here’s What Happened
by Danessa Lincoln · The Markets DailyAcasti Pharma Inc. (CVE:ACST – Get Free Report) was up 1.8% during mid-day trading on Tuesday . The company traded as high as C$0.58 and last traded at C$0.58. Approximately 2,450 shares changed hands during trading, a decline of 63% from the average daily volume of 6,576 shares. The stock had previously closed at C$0.57.
Acasti Pharma Price Performance
The business’s 50 day moving average price is C$0.58 and its 200 day moving average price is C$0.58. The stock has a market capitalization of C$18.19 million, a P/E ratio of -1.21 and a beta of 1.22.
About Acasti Pharma
Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.